Advances in monoclonal antibody therapy of cancer

Authors

Mansoor Saleh, Aga Khan UniversityFollow
Albert LoBuglio, University of Alabama at Birmingham, USA

Document Type

Article

Department

Haematology and Oncology, East Africa

Abstract

Tumor-associated antigens can be seen as unique targets for the delivery of anticancer therapy. Monoclonal antibodies directed at such antigens are increasingly being seen as important biologic reagents that will complement the group of existing cytotoxic drugs. This report briefly overviews recent advances in the field of monoclonal antibody therapy of cancer and provides insight regarding the promises and limitations of this novel therapeutic approach.

Comments

This work was published before the author joined Aga Khan University.

Publication (Name of Journal)

The American journal of the medical sciences

DOI

https://doi.org/10.1097/00000441-199209000-00011

Recommended Citation

Saleh, M., LoBuglio, A. (1992). Advances in monoclonal antibody therapy of cancer. The American journal of the medical sciences, 304(3), 214-224.
Available at: https://ecommons.aku.edu/eastafrica_fhs_mc_haematol_oncol/135